Recombinant zoster vaccine is associated with lower risk of dementia in adults aged ≥65 years

Abstract

Background: Vaccines to prevent herpes zoster, historically zoster vaccine live (ZVL), have been associated with reduced dementia risk. We evaluated the association between recombinant zoster vaccine (RZV) and reduction in all‐cause dementia in adults aged ≥65 years at Kaiser Permanente Southern California.